List of works by Paola Nisticò

3D models in the new era of immune oncology: focus on T cells, CAF and ECM

scientific article published on 22 March 2019

A cytofluorimetric assay to evaluate T cell polyfunctionality

scientific article published on 14 August 2019

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

scientific article published on October 1997

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

scientific article published on 13 January 2017

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

scientific article

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients

scientific article published on 11 September 2018

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

scientific article published on 06 September 2013

Autoantibody signature in human ductal pancreatic adenocarcinoma.

scientific article published on 8 September 2007

Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors

scientific article published on 01 February 2020

Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma ⬇️

scientific article published on September 1, 1992

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

scientific article published in January 2009

Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer

scientific article published on 10 June 2010

Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

scientific article published on 25 February 2020

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

scientific article published on 23 April 2019

Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"

scientific article published on 10 August 2020

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

scientific article published on 7 September 2010

Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting

scientific article

Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases

scientific article published on February 2012

Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

scientific article published on April 1990

Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

scientific article

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients

scientific article published on 01 December 1999

Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response

scientific article

Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines

scientific article published on August 2008

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer

scientific article published on 12 May 2017

Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.

scientific article

Low Frequency of ErbB-2 Proto-oncogene Overexpression in Human Leukocyte Antigen-A2-Positive Breast Cancer Patients

scientific article published on 01 February 1997

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon

scientific article published on 01 September 1990

Molecular and genetic bases of pancreatic cancer.

scientific article published on June 2012

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

scientific article

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

scientific article published on 12 April 2020

Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.

scientific article

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer

scientific article

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

scientific article published on February 2016

Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer

scientific article published on 11 April 2019

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

scientific article

Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors

scientific article

The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation

scientific article published on 10 September 2020

The cooperation between hMena overexpression and HER2 signalling in breast cancer

scientific article

The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.

scientific article published in March 2006

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

scientific article published on 12 August 2016

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 22 May 2019

hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.

scientific article published on 8 February 2018

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis

scientific article published on 15 June 2018

hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.

scientific article published on 11 May 2015

hMENA(11a), a hMENA isoform sending survival signals

scientific article published on 27 August 2015

β1 and β4 integrins: from breast development to clinical practice

scientific article

Paulina is supported by:

About Paulina

Help